Loading...
DESIGN OF THE SILENT CEREBRAL INFARCT TRANSFUSION (SIT) TRIAL
BACKGROUND: Silent cerebral infarct (SCI) is the most common cause of serious neurological disease in sickle cell anemia (SCA), affecting approximately 22% of children. The goal of this trial is to determine whether blood transfusion therapy will reduce further neurological morbidity in children wit...
Na minha lista:
Udgivet i: | Pediatr Hematol Oncol |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
2010
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5572477/ https://ncbi.nlm.nih.gov/pubmed/20201689 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/08880010903360367 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|